ChiCTR2600122261 版本V1.0 版本创建时间2026/04/10 16:29:14 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600122261 

最近更新日期:

Date of Last Refreshed on:

2026-04-10 16:28:32 

注册时间:

Date of Registration:

2026-04-10 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

老年前列腺癌根治术后患者社会隔离的干预方案构建及应用

Public title:

Construction and application of an intervention program for social isolation in elderly patients after radical prostatectomy

注册题目简写:

English Acronym:

研究课题的正式科学名称:

老年前列腺癌根治术后患者社会隔离的干预方案构建及应用

Scientific title:

Construction and application of an intervention program for social isolation in elderly patients after radical prostatectomy

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

朱雅婷 

研究负责人:

郭谊楠 

Applicant:

Zhu Yating 

Study leader:

Guo Yinan 

申请注册联系人电话:

Applicant telephone:

+86 183 5040 7025

研究负责人电话:

Study leader's
telephone:

+86 133 6591 0951

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

Yogurtti@163.com

研究负责人电子邮件:

Study leader's E-mail:

nangyi03@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

中国福建省福州市闽侯县大学城学府北路1号

研究负责人通讯地址:

中国福建省福州市鼓楼区新权路29号

Applicant address:

1 Xuefu North Road, University Town, Minhou County, Fuzhou, Fujian, China

Study leader's address:

29 Xinquan Road, Gulou District, Fuzhou, Fujian, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

福建医科大学

Applicant's institution:

Fujian Medical University

研究负责人所在单位:

福建医科大学附属协和医院

Affiliation of the Leader:

Fujian Medical University Union Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2026KY538

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

福建医科大学附属协和医院科研伦理委员会

Name of the ethic committee:

The Research Ethics Committee of Fujian Medical University Union Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2026-03-25 00:00:00

伦理委员会联系人:

蔡梅霞

Contact Name of the ethic committee:

Cai Meixia

伦理委员会联系地址:

中国福建省福州市鼓楼区新权路29号

Contact Address of the ethic committee:

29 Xinquan Road, Gulou District, Fuzhou, Fujian, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 183 5910 7569

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

福建医科大学附属协和医院

Primary sponsor:

Fujian Medical University Union Hospital

研究实施负责(组长)单位地址:

中国福建省福州市鼓楼区新权路29号

Primary sponsor's address:

29 Xinquan Road, Gulou District, Fuzhou, Fujian, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

福建

市(区县):

福州

Country:

China

Province:

Fujian

City:

Fuzhou

单位(医院):

福建医科大学附属协和医院

具体地址:

中国福建省福州市鼓楼区新权路29号

Institution
hospital:

Fujian Medical University Union Hospital

Address:

29 Xinquan Road, Gulou District, Fuzhou, Fujian, China

经费或物资来源:

自筹

Source(s) of funding:

Self-funded

研究疾病:

前列腺癌 ?  

Target disease:

Prostate cancer

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

非随机对照试验 

Study design:

Non randomized control 

研究目的:

探讨老年前列腺癌根治术后患者经历社会隔离的真实体验和需求,并构建出老年前列腺癌根治术后患者社会隔离的干预方案,并探讨对改善老年前列腺癌根治术后患者的可行性和有效性。  

Objectives of Study:

Explore the real experiences and needs of elderly prostate cancer patients who have undergone radical prostatectomy regarding social isolation, and construct an intervention plan for social isolation of such patients. Also, investigate the feasibility and effectiveness of this plan in improving the conditions of elderly prostate cancer patients after radical surgery.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1. 年龄>=60岁; 2. 接受前列腺癌根治术的患者; 3. 具备正常交流能力和认知功能; 4. 能使用智能手机或其他通讯工具进行干预活动; 5. 未参与其他心理或社会干预研究。

Inclusion criteria

1. Age >= 60 years old; 2. Patients who have undergone radical prostatectomy; 3. With normal communication ability and cognitive function; 4. Capable of using smart phones or other communication tools for intervention activities; 5. Not participating in other psychological or social intervention studies.

排除标准:

1. 认知或精神障碍; 2. 术后出现严重并发症或血流动力学不稳定; 3. 严重运动或活动受限,如瘫痪或骨关节疾病等; 4. 曾接受心理干预; 5. 1个月内经历过严重的创伤事件。

Exclusion criteria:

1. Cognitive or mental disorders; 2. Severe complications or hemodynamic instability after surgery; 3. Severe limitations in movement or activities, such as paralysis or bone and joint diseases; 4. Previously received psychological intervention; 5. Experienced a serious traumatic event within one month.

研究实施时间:

Study execute time:

From 2026-04-15 00:00:00 To 2027-01-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-04-15 00:00:00 To 2027-01-31 00:00:00

干预措施:

Interventions:

组别:

干预组

样本量:

40

Group:

Intervention group

Sample size:

干预措施:

在对照组基础上实施基于社会隔离认知行为模型的干预措施,包括鼓励积极的社会行为、树立正确的认知以及进行盆底肌锻炼等。

干预措施代码:

Intervention:

Based on the control group, intervention measures based on the social isolation cognitive behavioral model were implemented, including encouraging positive social behaviors, establishing correct cognition, and pelvic floor muscle exercises, etc.

Intervention code:

组别:

对照组

样本量:

40

Group:

Control group

Sample size:

干预措施:

实施常规护理,由责任护士完成,干预前护士长和科室教学秘书对责任护士的常规护理工作进行指导,其内容主要为前列腺癌患者常规护理与健康教育、出院指导及常规随访。

干预措施代码:

Intervention:

Conventional nursing was implemented, and it was carried out by the responsible nurses. Before the intervention, the head nurse and the department's teaching secretary provided guidance to the responsible nurses on their routine nursing work. The content mainly included routine nursing and health education for prostate cancer patients, discharge guidance, and routine follow-up.

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

福建 

市(区县):

 

Country:

China

Province:

Fujian

City:

单位(医院):

福建医科大学附属协和医院 

单位级别:

三甲 

Institution
hospital:

Fujian Medical University Union Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

社会隔离

指标类型:

主要指标

Outcome:

Social isolation

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

孤独感

指标类型:

次要指标

Outcome:

Loneliness

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

抑郁

指标类型:

次要指标

Outcome:

Depression

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

社会支持

指标类型:

次要指标

Outcome:

Social support

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

生活质量

指标类型:

次要指标

Outcome:

Quality of life

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

自我效能感

指标类型:

次要指标

Outcome:

Self efficacy

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 60 years
最大 Max age NA years

性别:

男性

Gender:

Male

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

由经过专门培训的资料收集员对数据进行测量和采集。采用excel 2019建立数据库,为保证数据录入的准确性,所有数据均由双人录入,并采用SPSS 26.0软件进行数据处理。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Specially trained data collectors were responsible for measuring and collecting the data. A database was established utilizing Excel 2019. To ensure data entry accuracy, two individuals independently entered the data, and data processing was conducted using SPSS 26.0 software.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2026-04-10 16:28:32